Jeegar Pravinkumar Patel has sold EVMN and made no open-market buys since Jun 2026

Patel Jeegar Pravinkumar is a corporate insider and Chief Scientific Officer (CSO) of Evommune, Inc. (NASDAQ: EVMN), a biotechnology company focused on developing therapies for immune-mediated inflammatory diseases.( As CSO, Patel is listed among Evommune’s key executives and top insiders alongside CEO Luis C. Peña and other senior leaders, reflecting a central role in guiding the company’s scientific strategy and R&D portfolio.(

In this capacity, Patel is a reporting insider in Evommune’s SEC filings and has recently engaged in notable insider stock transactions, including the sale of 16,687 shares of Evommune common stock at a price of approximately $22.74 per share in early June 2026.( These transactions, disclosed through insider trading reports and market news services, underscore Patel’s significant equity stake and direct financial alignment with the company’s performance.( Public sources identify Patel as an individual executive but currently do not provide additional verified details on prior career history or educational background.(

Written by Perplexity from public sources.